223
Views
2
CrossRef citations to date
0
Altmetric
Gynaecology

Use of steroid pre-treatments in IVF-ICSI cycles with GnRH antagonist protocol and their impact on gestational outcomes

, , , , , , , , & show all

References

  • Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. 2016. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews 29(4):CD001750.
  • Andersen AN, Witjes H, Gordon K, Mannaerts B. 2011. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Human Reproduction 26(12):3413–3423.
  • Bermejo A, Iglesias C, Ruiz-Alonso M, Blesa D, Simón C, Pellicer A, et al. 2014. The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity. Human Reproduction (Oxford, England) 29(6):1271–1278.
  • Blockeel C, Engels S, De Vos M, Haentjens P, Polyzos NP, Stoop D, et al. 2012. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reproductive Biomedicine Online 24(3):272–280.
  • Cédrin-Durnerin I, Bständig B, Parneix I, Bied-Damon V, Avril C, Decanter C, et al. 2007. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Human Reproduction 22(1):109–116.
  • Cédrin-Durnerin I, Guivarc'h-Levêque A, Hugues J-N. 2012. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial. Fertility and Sterility 97(6):1359–1364.
  • de Ziegler D, Jääskeläinen AS, Brioschi PA, Fanchin R, Bulletti C. 1998. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Human Reproduction 13(3):561–564.
  • Dragisic KG, Davis OK, Fasouliotis SJ, Rosenwaks Z. 2005. Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertility and Sterility 84(4):1023–1026.
  • Fanchin R. 2003. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Human Reproduction 18(12):2698–2703.
  • Farquhar C, Rombauts L, Kremer JA, Lethaby A, Ayeleke RO. 2017. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews 25(5):CD006109.
  • Fauser BC. 2019. Towards the global coverage of a unified registry of IVF outcomes. Reproductive Biomedicine Online 38(2):133–137.
  • Frattarelli JL, Hill MJ, McWilliams GDE, Miller KA, Bergh PA, Scott RT, et al. 2008. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertility and Sterility 89(5):1118–1122.
  • Frydman R, Forman R, Rainhorn JD, Belaisch-Allart J, Hazout A, Testart J, et al. 1986. A new approach to follicular stimulation for in vitro fertilization programed oocyte retrieval. Fertility and Sterility 46(4):657–662.
  • Garcia-Velasco JA, Fatemi HM. 2015. To pill or not to pill in GnRH antagonist cycles: that is the question! Reproductive Biomedicine Online 30(1):39–42.
  • Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B. 2010. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertility and Sterility 94(6):2382–2384.
  • Guivarc’h-Levêque A, Homer L, Arvis P, Broux PL, Moy L, Priou G, et al. 2011. Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes? Fertility and Sterility 96(4):872–876.
  • Hauzman EE, Zapata A, Bermejo A, Iglesias C, Pellicer A, Garcia-Velasco JA, et al. 2013. Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial. Reproductive Biology and Endocrinology 11(11):96.
  • Hill MJ, McWilliams GDE, Miller KA, Scott RT, Frattarelli JL. 2009. A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates. Fertility and Sterility 91(3):739–743.
  • Huirne JA, van Loenen AC, Donnez J, Pirard C, Homburg R, Schats R, et al. 2006. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reproductive BioMedicine Online 13(2):235–245.
  • Huirne JA, van Loenen AC, Schats R, McDonnell J, Hompes PG, Schoemaker J, et al. 2005. Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Human Reproduction 20(2):359–367.
  • Kim C-H, Jeon G-H, Cheon Y-P, Jeon I, Kim S-H, Chae H-D, et al. 2009. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection. Fertility and Sterility 92(5):1758–1760.
  • Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P, et al. 2006. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Human Reproduction 21(2):352–357.
  • Nejad EST, Ghaleh FB, Eslami B, Haghollahi F, Bagheri M, Masoumi M. 2018. Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: an RCT. International Journal of Reproductive BioMedicine 16(8):535–540.
  • Rombauts L, Healy D, Norman RJ. 2006. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Human Reproduction 21(1):95–103.
  • Saple S, Agrawal M, Kawar S. 2016. Precycle estradiol in synchronization and scheduling of antagonist cycles. Journal of Obstetrics and Gynaecology of India 66(4):295–299.
  • Sefrioui O, Madkour A, Kaarouch I, Louanjli N. 2019. Luteal estradiol pretreatment of poor and normal responders during GnRH antagonist protocol. Gynecological Endocrinology 35(12):1067–1071.
  • Shoorei H, Banimohammad M, Kebria MM, Afshar M, Taheri MMh, Shokoohi M, et al. 2019. Hesperidin improves the follicular development in 3D culture of isolated preantral ovarian follicles of mice. Experimental Biology and Medicine 244(5):352–361.
  • Vander Borght M, Wyns, C. 2018. Fertility and infertility: definition and epidemiology. Clinical Biochemistry 62:2–10.
  • Wardle PG, Foster PA, Mitchell JD, McLaughlin EA, Williams JA, Corrigan E, et al. 1986. Norethisterone treatment to control timing of the IVF cycle. Human Reproduction 1(7):455–457.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.